about
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityRisk of ovarian cancer in women treated with ovarian stimulating drugs for infertilityControlled ovarian hyperstimulation for IVF: impact on ovarian, endometrial and cervical cancer--a systematic review and meta-analysisIVF and breast cancer: a systematic review and meta-analysisUse of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study.Fertility drug use and risk of ovarian tumors: a debated clinical challenge.Use of fertility drugs and risk of ovarian cancer.Epidemiological characteristics of ovarian cancer in Korea.Participation in investigational fertility preservation research: a feminist research ethics approach.Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control studyFertility drugs and gynecologic cancer.Payment of egg donors in stem cell research in the USA.Cancer risk after exposure to treatments for ovulation induction.Ovarian stimulation: is there a long-term risk for ovarian, breast and endometrial cancer?Long-term complications of assisted reproductive technologies.Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up.Restoration of endocrine function and fertility with orthotopic tubal-ovarian allotransplant as the anatomical-functional unit in rabbits.Development of second primary cancer in Korean breast cancer survivors.Overweight negatively affects outcome of superovulation treatment in female mice.Ovarian melanoma complicating pregnancy achieved by in-vitro fertilisation.Comparison of pregnancy outcomes in natural cycle IVF/M treatment with or without mature oocytes retrieved at time of egg collection.In vitro maturation: a five-year experience.Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility.Repeated superovulation increases the risk of osteoporosis and cardiovascular diseases by accelerating ovarian aging in mice.
P2860
Q24200437-79745CBA-8E31-4AE9-B2D1-4E6FF59B764CQ24241692-901F70EA-A53D-4C02-9C6F-66EEC74820B6Q28281796-A923CE6A-77E9-4FD6-81B0-C25969336BFAQ28295207-AF72DFBA-5CBB-4CC7-9E61-BB3879511B91Q34015977-90E801BC-1586-4729-98EE-2BF77AC67EE1Q34297428-FD81FDDF-EFFC-4C2D-A097-543EB3787F00Q34443562-763B7495-88E1-4268-98FF-88A45CABE6EAQ34517726-3BCF0738-731E-4F84-9DAE-5CDCB3E2F861Q34766262-34A74C02-99DD-4280-BB11-B6B62573DF8CQ35540547-F0D8A3A7-826A-4427-9F9B-F0A34DB85F6CQ36153070-A8410203-6B7F-47AE-B62B-AF6B6AE465D9Q36739230-6E6BAB35-A455-44D8-9166-1717B3DBAF29Q36887108-7D00EA2C-EEEC-410C-AD28-B2EB4EA007E0Q37288901-AB5A200D-AE94-4414-BA95-A4D6C854F620Q37813695-14DD8386-A780-4FA8-BA2A-78EE0CFD44B0Q37883367-91D92763-C0E9-413D-BC5B-C128CB5A0621Q44064662-E8183F36-96A9-4804-BE1B-53AC83C17641Q46153038-3748D6E9-56A8-45CA-9D32-CF28D912165DQ47157751-6BF339F7-9EE1-4BBF-B536-672F5D70B816Q47573145-2723F211-1CC3-48E8-8282-38BDEC513BD8Q48245424-2B7706D0-02CC-469F-9392-77C65291D31BQ48656147-367748E2-038A-4AA9-94CB-A7BC190D7800Q48663264-2F257414-2068-431D-9734-27503A9BB467Q53347851-890A9747-38D9-4A51-A301-D19B972609CBQ55100497-BC63F6BB-0D84-4AFB-9A57-CB2566D42804
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Ovulation induction and cancer risk.
@ast
Ovulation induction and cancer risk.
@en
type
label
Ovulation induction and cancer risk.
@ast
Ovulation induction and cancer risk.
@en
prefLabel
Ovulation induction and cancer risk.
@ast
Ovulation induction and cancer risk.
@en
P2093
P1476
Ovulation induction and cancer risk.
@en
P2093
Bert Scoccia
Carolyn L Westhoff
Emmet J Lamb
Kamran S Moghissi
P304
261-74; quiz 525-6
P356
10.1016/J.FERTNSTERT.2004.09.016
P407
P577
2005-02-01T00:00:00Z